Another CAR-T MUC1 currently in clinical evaluation is huMNC2-CAR44, targeting MUC1*, the extra cellular domain of the cleaved form of MUC1, present on a large percentage of solid tumors, including breast cancer (NCT04020575). The gene discussed is MUC1; the disease is breast cancer.